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The tumor suppressor adenomatous polyposis coli (APC) is mutated in the majority of colorectal cancers and is best
known for its role as a scaffold in a Wnt-regulated protein complex that determines the availability of -catenin. Another
common feature of solid tumors is the presence of hypoxia as indicated by the up-regulation of hypoxia-inducible factors
(HIFs) such as HIF-1. Here, we demonstrate a novel link between APC and hypoxia and show that APC and HIF-1
antagonize each other. Hypoxia results in reduced levels of APC mRNA and protein via a HIF-1–dependent mechanism.
HIF-1 represses the APC gene via a functional hypoxia-responsive element on the APC promoter. In contrast, APC-
mediated repression of HIF-1 requires wild-type APC, low levels of -catenin, and nuclear factor-B activity. These
results reveal down-regulation of APC as a new mechanism that contributes to the survival advantage induced by hypoxia
and also show that loss of APC mutations produces a survival advantage by mimicking hypoxic conditions.
INTRODUCTION
The adenomatous polyposis coli (APC) tumor suppressor is
the most commonly mutated gene in colorectal cancer (Pow-
ell et al., 1992). The APC protein is involved in many of the
fundamental processes that govern normal gut epithelium.
It is best known for controlling the Wnt/–catenin pathway,
where it regulates -catenin levels, thereby regulating the
transcriptional activity of T-cell factor (TCF)/lymphoid-en-
hancing factor (LEF) transcription factors (Bienz and Clev-
ers, 2000). APC also contributes to the regulation of cytoskel-
etal proteins (McCartney and Nathke, 2008). Importantly,
APC is mutated in the human syndrome familial adenoma-
tous polyposis (FAP). FAP patients are heterozygous for
APC and develop hundreds of polyps in their gut that
invariably become cancerous if left untreated (Ichii et al.,
1993; Fearnhead et al., 2001). The progression to malignancy
probably involves inﬂammation and hypoxia (O’Byrne et al.,
2000; Rajaganeshan et al., 2008).
Hypoxia is an important stimulus for tumor angiogenesis
and growth (O’Byrne et al., 2000; Garcia, 2006). The tran-
scriptional response to hypoxia is mainly controlled by the
hypoxia-inducible factor (HIF) system (Bardos and Ashcroft,
2005). HIF is a heterodimeric transcription factor composed of
 and  subunits. Although HIF-1 is constitutively expressed,
HIF- subunits are extremely labile at normal oxygen levels.
HIF-1 levels respond to oxygen through posttranslational
hydroxylation, which is catalyzed by a class of 2-oxogluta-
rate dioxygenases called prolyl-hydroxylases (PHDs). Hy-
droxylation of speciﬁc proline residues in the oxygen-depen-
dent degradation domain of HIF-1 targets it for
ubiquitination by the Von Hippel Lindau system and sub-
sequent degradation by the proteasome (Fandrey et al., 2006;
Bruegge et al., 2007). When oxygen levels are reduced, or
cofactors such as iron ions are not available, PHD activity is
inhibited so that HIF-1 levels increase, translocates into the
nucleus, and transactivates its target genes. Among the HIF-1
targets are PHD2 and PHD3, which create a negative feedback
loop for the system (Metzen et al., 2005; Pescador et al., 2005).
The HIF-1 gene is under the control of nuclear factor
(NF)-B (Gorlach and Bonello, 2008; Rius et al., 2008; van
Uden et al., 2008) and the chromatin remodelling complex
SWI/SNF (Kenneth et al., 2009). NF-B is the collective name
for a family of important transcription factors that control
many cellular processes, such as apoptosis and proliferation
(reviewed in Perkins and Gilmore, 2006). Impairment of
NF-B results in the loss of HIF-1 mRNA (Rius et al., 2008;
van Uden et al., 2008), which reduces HIF-1 levels in re-
sponse to hypoxia or proteasomal inhibition (Rius et al.,
2008; van Uden et al., 2008). This causes inappropriate cel-
lular responses to hypoxia in cells lacking normal NF-B
(van Uden et al., 2008; Kenneth et al., 2009).
HIF-1 and -catenin are also functionally connected (Kaidi
et al., 2007; Lim et al., 2008). Speciﬁcally, HIF-1 can interfere
with coactivation of TCF/LEF transcription mediated by
-catenin. Furthermore, -catenin can bind and regulate NF-B
activity (Deng et al., 2002, 2004; Du et al., 2009). Despite the estab-
lished relationship between HIF-1, NF-B, and Wnt/-catenin, a
link between APC and HIF-1 has not been investigated.
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3630Here, we report functional cross-talk between HIF-1 and
APC at the transcriptional level. Depletion of HIF-1 results
in increased APC mRNA and protein. Consistent with direct
transcriptional repression of APC by HIF-1, we discovered
a hypoxia-responsive element (HRE) in the APC promoter
and demonstrate that hypoxia induces HIF-1 binding to
this site. Importantly, hypoxia promotes a reduction in APC
mRNA and protein in different cells suggesting that sup-
pression of APC by hypoxia may be involved in increased
survival in hypoxic conditions in tumors with wild-type
APC. Interestingly, APC depletion results in increased
HIF-1 levels and activity. This increase is mediated by
NF-B and requires regulation of -catenin by APC. Our
results also suggest that cells lacking APC are adapted to
hypoxia and hence have a survival and proliferative advan-
tage under hypoxic conditions. This could be an important
factor in the progression of colorectal tumors.
MATERIALS AND METHODS
Cells
U2OS were obtained from American Type Culture Collection (Manassas, VA).
HCT-116 (parental, HA 85, and HA 18) were a kind gift from Prof. T.
Waldman (Georgetown University, Washington DC). SW480 and DLD-1 (Li
and Nathke, 2005) were grown in DMEM (Lonza Verviers, Verviers, Belgium)
supplemented with 10% fetal bovine serum (Invitrogen, Paisley, United King-
dom), 50 U/ml penicillin (Lonza Verviers), and 50 g/ml streptomycin
(Lonza Verviers) for no 30 passages. U2OS-HRE luciferase cells were a kind
gift from Dr. Margaret Ashcroft (University College, London, UK) and have
been described previously (Bardos et al., 2004; Kenneth et al., 2009).
Small Interfering RNA (siRNA) Transfection
siRNA duplex oligonucleotides were synthesized by Euroﬁns MWG Operon
(Huntsville, AL) and transfected using Oligofectamine (Invitrogen) and IN-
TERFERin (Polyplus, Illkirch, France) as per the manufacturer’s instructions.
siRNA sequences are as follows: control, AACAGUCGCGUUUGCGACUGG
(van Uden et al., 2008); (a) HIF-1-CUGAUGACCAGCAACUUGA (van Uden
et al., 2008) and (b) HIF-1-GGAAUUGGAACAUUAUUAC; APC (Dharma-
Figure 1. HIF-1 represses APC gene ex-
pression. (A) U2OS, HCT-116. Ha18, Ha85,
SW480, and DLD-1 cells were exposed to 1%
O2 for 24 h before harvest. Whole cell lysates
were analyzed by immunoblot blot using the
indicated antibodies. (B) U2OS cells were ex-
posed to 1% O2 for the indicated periods be-
fore total RNA or whole cell lysates extrac-
tion. RT-qPCR for APC was performed with
actin as a reference. The graph depicts the
mean plus SD of a minimum of three inde-
pendent experiments performed in duplicate.
Whole cell lysates were analyzed by immu-
noblot blot using the indicated antibodies. (C)
U20S, HCT-116, and HA18 cells were trans-
fected with control and HIF-1 siRNA oligo-
nucleotides (a and b) for 48 h before total
RNA extraction. RT-qPCR for APC and
HIF-1 was performed with actin as a refer-
ence gene. The graph depicts the mean plus
SD of a minimum of three independent ex-
periments performed in duplicate. (D) U2OS
cells were transfected with control, APC, and
HIF-1 siRNA oligonucleotides for 48 h. Cells
were exposed to 1% O2 for 24 h before har-
vest. Whole cell lysates were analyzed by
Western blot using the indicated antibodies.
Asterisk (*) indicates the level of signiﬁcance.
*p  0.05, **p  0.01, and ***p  0.005.
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Vol. 21, November 1, 2010 3631con RNA Technologies, Lafayette, CO) (Dikovskaya et al., 2007); and RelA,
GCUGAUGUGCACCGACAAG (Anderson and Perkins, 2003). Unless stated,
HIF-1 sequence (a) was mostly used throughout this study.
Mouse Tissue and Staining
Tissue samples of mouse small intestine were a kind gift from Dr. Owen Sansom
(CRUK Beatson Institute, Glasgow, United Kingdom). Tissue was harvested
from (AhCre Apcﬂ/ﬂ) mice 4 d after APC deletion from the intestinal crypt and
stem cells (Sansom et al., 2004). APC was deleted from the intestinal epithelium
by inducing Cre-mediated recombination with -naphtoﬂavone as described
previously (Sansom et al., 2004), and mice were treated with 20 mg/kg i.p. Taxol
(paclitaxel, Mayne Pharma, Salisbury South, SA. Australia), a microtubule stabi-
lizer 3 h (h) before tissue was harvested. Taxol treatment arrests cell in mitosis
and makes APC-depleted regions of the gut more visible. Gut tissue was ﬁxed in
4% paraformaldehyde and processed into wax blocks. Dewaxed sections were
placed in citrate buffer and antigen retrieved in a pressure cooker. After cooling
overnight, slides were rinsed in phosphate-buffered saline (PBS) 2  10 min and
permeabilized with 1% Triton X-100 in PBS for 20 min. After a rinse in PBS, slides
were blocked for 2 h with MAXblock (Active Motif, Carlsbad, CA) at room
temperature. Slides were incubated with CA9 antibody at a dilution of 1:500 in
working buffer (WB: 0.1% bovine serum albumin, 0.3% normal goat serum, and
0.2% Triton X-100 in PBS, pH 7.4) overnight at 4°C. After 5  5-min rinses in WB,
slides were incubated in secondary antibody goat ant-rabbit Alexa 647 (Invitro-
gen; 1:250) for1ha troom temperature. After 5  5-min rinses in WB and 3 
5-min rinses in PBS, cell nuclei were counterstained with 4,6-diamidino-2-phe-
nylindole in PBS. After rinsing in PBS, sections were mounted in Prolong Gold
(Invitrogen). Slides were imaged on a DeltaVision Core microscope system
(Applied Precision, Seattle, WA), and images were deconvolved using softWoRx
(Applied Precision).
Hypoxia Inductions and MG132 Treatment
Cells were incubated at 1% O2 in an InVIVO 300 hypoxia workstation (Ruskin
Technologies, Bridgend, United Kingdom). Cells were lysed for protein and
RNA extraction in the workstation to avoid reoxygenation. MG132 (Merck
Biosciences, Darmstadt, Germany) at 50 M was added 3 h before cell
harvesting.
Chromatin Immunoprecipitation (ChIP)
Proteins were cross-linked with formaldehyde for 10 min. Then, 0.125 mol/l
glycine was added, and cells were washed with PBS. Cells were lysed with
lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, 1 mM phenyl-
methylsulfonyl ﬂuoride, 1 mg/ml leupeptin, and 1 mg/ml aprotonin), fol-
lowed by sonication and centrifugation. The supernatant was precleared with
sheared salmon sperm DNA and protein G-Sepharose beads (Sigma Chemi-
cal/Generon, Berkshire, UK). Supernatant was incubated with speciﬁc anti-
bodies overnight and then with protein G-Sepharose beads for 1 h. After
extensive wash step, the complexes were eluted with buffer (100 mmol/l
NaHCO3 and 1% SDS) and incubated with proteinase K. DNA was puriﬁed
using polymerase chain reaction (PCR) puriﬁcation kit (QIAGEN/National
Blood Service, Burmingham, United Kingdom). PCR was performed using the
following primers: CA9 promoter (HRE), forward, GACAAACCTGT-
GAGACTTTGGCTCC and reverse, AGTGACAGCAGCAGTTGCACAGTG;
and APC HRE2, forward, TAGGGCTAGGCAGGCTGTG and reverse, CTG-
CACCAATACAGCCACAT.
Colony Formation Assay
Cells were plated at 5000 or 10,000 cells per well of six-well plates and grown
for 8 d after which cells were washed with PBS and stained with crystal violet.
Plates were scanned, and number of colonies was counted using ImageJ
software (National Institutes of Health, Bethesda, MD).
Antibodies
Antibodies used were as follows: HIF-1 (MAB1536, R&D Systems), CA9
(NB100-417; Novus Biologicals. Littleton, CO), -actin (A5441; Sigma Chem-
ical), Glut3 (RB-9096; Neomarkers, Fremont, CA), RelA (sc-372; Santa Cruz
Biotechnology, Santa Cruz, CA), phospho-Ser536 RelA (3033; Cell Signaling
Technology, Danvers, MA), phospho-Ser32/36 inhibitor of B( I B-) (9246;
Cell Signaling Technology), IB- (4812; Cell Signaling Technology), HIF-1
(3718; Cell Signaling Technology), APC (Nathke et al., 1996), -tubulin (T9026;
Sigma Chemical), -catenin (4270; Cell Signaling Technology; Dikovskaya et
al., 2007), BNIP3 (Ab10433; Abcam, Cambridge, United Kingdom), Chk1
(sc-8408; Santa Cruz Biotechnology), cyclin D1 (2926; Cell Signaling Technol-
ogy), and LC3B (2775; Cell Signaling Technology or sc-16756; Santa Cruz
Biotechnology). ChIP antibodies used were as follows: HIF-1 (sc-10790;
Santa Cruz Biotechnology), HIF-1 (sc-5580; Santa Cruz Biotechnology),
acetyl-H3 (06-599; Millipore, Billerica, MA), and polymerase II (Pol II) car-
boxy-terminal domain (sc-47701; Santa Cruz Biotechnology).
RNA, cDNA, and Quantitative (q)PCR
Total RNA was extracted using Invisorb spin cell RNA (Invitek, Hayward,
CA) or PeqLab Gold RNA extraction kit, according to the manufacturer’s
directions. RNA was converted to cDNA using Quantitect reverse transcrip-
tion kit (QIAGEN). Brilliant II SYBR Green kit (Stratagene/Agilent Technol-
ogies, Santa Clara, CA) was used, and samples analyzed using a Mx3005P
qPCR machine and software (Stratagene/Agilent).
qPCR Oligonucleotides Sequences
qPCR oligonucleotides sequences were as follows: actin, forward, CTGG-
GAGTGGGTGGAGGC and reverse, TCAACTGGTCTCAAGTCAGTG; RelA,
forward, CTGCCGGGATGGCTTCTAT and reverse, CCGCTTCTTCACA-
CACTGGAT; HIF-1, forward, CATAAAGTCTGCAACATGGAAGGT and
reverse, ATTTGATGGGTGAGGAATGGGTT; APC, forward, TGTCCCTC-
CGTTCTTATGGAA and reverse, TCTTGGAAATGAACCCATAGGAA;
CA9, forward, CTTTGCCAGAGTTGACGAGG and reverse, CAGCAACT-
GCTCATAGGCAC; Glut3, forward, CAATGCTCCTGAGAAGATCATAA
and reverse, AAAGCGGTTGACGAAGAGT; and ADM, forward, GGAA-
GAGGGAACTGCGGATGT and reverse, GGCATCCGGACTGCTGTCT.
Statistical Analysis
Analysis of variance and Student’s t tests were performed on the means, and
p values were calculated (*p  0.050, **p  0.010, and ***p  0.005.
Other Experimental Procedures
Immunoblots, transfections, and luciferase assays have been described pre-
viously (Rocha et al., 2005; Schumm et al., 2006; Dikovskaya et al., 2007, and
references therein).
RESULTS
APC Is Repressed Directly by HIF-1 during Hypoxia
Hypoxia is a common feature of most solid tumors and is
thought to contribute to tumor progression and therapy
evasion (Garcia, 2006). In colorectal cancer, APC mutation
occurs early and subsequent genetic alterations drive tumor-
igenesis. Given the importance of hypoxia in cancer, we
investigated whether hypoxia modulated APC function in
cells. Immunoblotting protein from a variety of cell lines
after hypoxia treatment showed that hypoxia resulted in
Figure 2. APC is a direct HIF-1 target. (A) ChIP analysis for
HIF-1 binding to the APC and CA9 promoters. U2OS cells were
exposed to 1% O2 for the indicated periods before ﬁxation and lysis.
HIF-1-bound DNA was ampliﬁed with speciﬁc primers spanning
the annotated HRE region on the CA9 and the putative HRE at the
APC promoter. Rabbit immunoglobulin G (IgG) was used as a
control for the immunoprecipitation. Input represents 10% of the
starting material used per immunoprecipitation (IP). (B) ChIP anal-
ysis for HIF-1 binding at the APC and CA9 promoters. U2OS cells
were exposed to 1% O2 for 24 h before ﬁxation and lysis. HIF-1–
bound DNA was ampliﬁed with speciﬁc primers spanning the
annotated HRE region on the CA9 and the putative HRE at the APC
promoter. Rabbit IgG was used as a control for the immunoprecipi-
tation. Input represents 10% of the starting material used per IP. (C)
ChIP for AcH3. (D) Polymerase II at the APC HRE site. Cells were
treated and processed as described in B. Rabbit IgG was used as a
negative control. APC HRE site was ampliﬁed using speciﬁc PCR
primers. Inputs represent 10% of starting material used in each IP.
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mutation status (Figure 1A). In addition, in U2OS cells,
which express wild-type APC, hypoxia resulted in increased
-catenin stabilization (Figure 1A).
To determine whether hypoxia changed APC gene tran-
scription, we used reverse transcriptase (RT) followed by
qPCR to measure APC mRNA at different times after hyp-
oxia exposure (Figure 1B). Our analysis revealed that hyp-
oxia results in decreased APC mRNA levels in a time-de-
pendent manner corresponding to HIF-1 stabilization
(Figure 1B and Supplemental Figure 1A).
A key response to hypoxia is activation of the transcrip-
tion factor HIF-1. To determine whether hypoxia-mediated
APC inhibition was HIF-1 dependent, we depleted HIF-1
by using siRNA and measured APC mRNA levels (Figure
1C). HIF-1 depletion in all cells tested using two different
siRNA oligonucleotides, resulted in increased levels of APC
mRNA in normoxia (Figure 1C). Similar results were also
observed in hypoxia (Supplemental Figure 1B). This corre-
lated with increased APC protein in cells depleted of HIF-1
(Figure 1D). Together, these results indicate that HIF-1
represses APC gene expression.
APC Is a Direct HIF-1 Target
Hypoxia results in reduced expression of APC, and HIF-1
depletion by RNA interference increased APC mRNA and
protein levels. To determine whether APC is a direct target
of HIF-1, we analyzed the APC promoter region using
MattInspector, which revealed two putative HIF-1 binding
sites located in the APC promoter (accession U02509). ChIP
using a HIF-1 antibody revealed speciﬁc and inducible
HIF-1 binding to region 2 but not the putative HIF-1
binding site 1 (Figure 2A; data not shown). The CA9 pro-
moter was used as a positive control. Hypoxia induces rises
in HIF-1 protein due to increased stability. As such, it was
possible that the observed HIF-1 recruitment to these pro-
moters was merely a consequence of increased protein levels
in the cell. To rule out this possibility, we performed ChIP
experiments with the HIF-1 binding partner HIF-1, whose
levels are unaltered by hypoxia exposure (Figure 2B). The
results clearly demonstrate that hypoxia induces an in-
creased recruitment of HIF-1 to both the CA9 and the APC
promoters (Figure 2B), further conﬁrming a direct role for
the HIF-1 transcription factor in the repression of the APC
promoter. Importantly, binding of HIF-1 to the APC pro-
moter was accompanied by hallmarks of repressed tran-
scription, speciﬁcally a reduction in the recruitment of RNA
Pol II (Figure 2C) and in the levels of AcH3 after exposure to
hypoxia (Figure 2D and Supplemental Figure 2). These ex-
periments revealed that hypoxia-activated HIF-1 represses
the APC promoter directly by occupying a speciﬁc site on
Figure 3. APC depletion increases HIF-1
levels and activity. (A) U2OS-HRE luciferase
cells were transfected with the indicated
siRNA oligonucleotides. Where indicated,
cells were exposed to 1% O2 for 24 h before
harvest. Luciferase activity was analyzed 48 h
posttransfection. Graph depicts the mean plus
SD of a minimum of two independent exper-
iments performed in duplicate. (B) U2OS cells
were transfected with control and APC
siRNA oligonucleotides for 48 h before total
RNA extraction. Where indicated, cells were
exposed to 1% O2 for 24 h. After cDNA syn-
thesis, qPCR was performed for APC and
HIF-1 mRNA. Levels were normalized to
actin mRNA, and the graph depicts the mean
plus SD of a minimum of three independent
experiments performed in duplicate. (C)
U2OS cells were transfected with siRNA oli-
gonucleotides as indicated and exposed or
not to 1% O2 for 24 h before harvest. Whole
cell lysates were analyzed by Western blot to
detect the levels of APC, HIF-1, and the
HIF-1 target Glut3. Actin and HIF-1 were
used as loading controls. (D) U2OS cells were
treated as described in B, and qPCR was per-
formed for the HIF-1 target genes as indi-
cated. Asterisk (*) indicates the level of signif-
icance. *p  0.05, **p  0.01, and ***p  0.005.
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and providing crucial insight into the poorly understood
transcriptional control of this important tumor suppressor.
APC Depletion Increases HIF-1 Message, Protein, and
Transcriptional Activity
To determine the effect of the APC tumor suppressor on the
activity of HIF-1, we performed luciferase reporter assays
in a U2OS reporter cell line that has been used extensively to
measure HIF-1 transcriptional activity (Bardos et al., 2004;
Kenneth et al., 2009). Cells were transfected with previously
validated siRNA oligonucleotides that target APC (Dik-
ovskaya et al., 2007) and HIF-1 (Kenneth et al., 2009). In
addition, cells were exposed to 1% O2 for 24 h before har-
vest. As expected, depletion of HIF-1 abolished hypoxia-
induced luciferase activity, conﬁrming loss of HIF-1 (Fig-
ure 3A). Depletion of APC, in contrast, resulted in a
signiﬁcant increase in HIF-1 activity (Figure 3A).
To establish whether the mechanism responsible for in-
creased HIF-1 transcriptional activity in response to APC loss
involved transcriptional changes, APC levels were depleted
using siRNA oligonucleotides and total RNA was extracted.
RT-qPCR was used to measure APC and HIF-1 mRNA levels.
APC siRNA reduced APC mRNA signiﬁcantly in U2OS cells
(Figure 3B). Surprisingly, this reduction in APC was accompa-
nied by a signiﬁcant increase of HIF-1 mRNA (Figure 3B).
These effects also were observed after hypoxia treatment (Fig-
ure 3B). Slight changes in HIF-1 mRNA can cause signiﬁcant
changes in HIF-1 protein levels and activity (van Uden et al.,
2008; Kenneth et al., 2009), so we determined whether APC
depletion also increased HIF-1 protein and its endogenous
target genes. U2OS cells were transfected with APC siRNA and
exposed to 1% O2 for 24 h before harvest. Immunoblotting
showed that APC depletion produced an increase in basal
levels of HIF-1 and a further increase in hypoxia-stabilized
HIF-1 protein (Figure 3C). Similar results were observed
when cells were treated with the proteasome inhibitor MG132,
where APC depletion resulted in higher HIF-1 protein levels
(Supplemental Figure 3A). In addition, the Glut3 protein (a
known HIF-1 target) was also increased when APC was ab-
sent (Figure 3C). Importantly, transcripts of several HIF-1
target genes such as Glut3, CA9, PHD2, and ADM also were
increased both in normoxia and hypoxia when APC was de-
pleted (Figure 3D and Supplemental Figure 3B). These results
establish that APC depletion leads to HIF-1 activation.
APC Modulation of HIF-1 Requires Wild-Type APC
To determine whether our ﬁndings were also evident at the
organism level, we investigated the effects of APC depletion
in vivo. Using tissue harvested from AhCre Apcﬂ/ﬂ mice 4 d
after APC deletion from the intestinal crypt, we visualized
the levels of the HIF-1 target CA9 (Sansom et al., 2004). In
wild-type tissue, CA9 was localized to the cell cortex in
differentiated cells and only weakly detectable in crypts
(Figure 4A). APC depletion in cells toward the base of the
crypt resulted in disorganized epithelium (Sansom et al.,
2004) with increased CA9 staining indicating higher HIF-1
activity (Figure 4A). Because Cre-activation and thus APC
depletion is initiated in the proliferative compartment of the
crypt, cells toward the tip of the villus in these sections are still
wild type for APC (Sansom et al., 2004) and, like control tissue,
they showed only weak staining for CA9. These results indi-
cate that APC depletion results in activation of HIF-1 in the
context of a tissue conﬁrming our biochemical data.
APC is mutated in the majority of colorectal cancers and
these tumors often have elevated HIF-1 protein levels
(Furlan et al., 2008). To establish whether mutant APC can
still regulate HIF-1, we determined whether depletion of
mutant APC also resulted in increased HIF-1 levels. For
this purpose, we analyzed SW480 and DLD-1 cells. Both
express only truncated, mutant APC (Li and Nathke, 2005;
Figure 4B). Because HIF-1 protein is usually kept at low
levels by O2-dependent proteasomal degradation, any
changes in HIF-1 mRNA can be visualized using the pro-
teasome inhibitor MG132 (Bardos et al., 2004; Kenneth et al.,
2009). When APC was depleted in either of these cell types,
no changes in HIF-1 protein were detected (Figure 4B),
suggesting that mutant APC cannot modulate HIF-1 levels.
APC Modulation of HIF-1 Requires Wild-Type
-Catenin
One of the main functions of APC is to limit Wnt/–catenin
signaling, so it was important to determine whether increases
in HIF-1 induced by depletion of APC were due to changes in
-catenin. Using a panel of isogenic HCT-116 cells that express
either mutant (stabilized and thus not sensitive to APC regu-
lation) and wild type -catenin (parental), or only wild-type
-catenin (HA85), or only mutant (HA18) -catenin, we
repeated the depletion of APC, treated with hypoxia, and
Figure 4. Depletion of APC increases HIF-1 activity in situ. (A)
CA9 staining of wild-type (WT) and APC-depleted mouse small
intestine. Maximum intensity projections of wideﬁeld, deconvolved
images show cortical localization of CA9 in crypts from WT tissue
(arrowhead), except in Paneth cells at the base of the crypt, which
show little or no staining. APC-depleted cells toward the base of the
crypt/villus axis (arrow) form a disorganized epithelium and ele-
vated CA9 homogenously in the cytoplasm. Because Cre-activation
and thus APC depletion only occurs in the proliferative compart-
ment of the crypt, the same tissue section also shows cells toward
the tip of the villus (arrowhead) that are wild type for APC, and, like
control tissue, show only weak staining for CA9. Bars, 20 m. (B)
SW480 and DLD-1 cells were transfected with control and APC
siRNA oligonucleotides and treated where indicated with 50 M
MG132 for 3 h before harvest. Whole cell lysates were analyzed by
Western blot using the indicated antibodies.
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analysis revealed that although in parental and mutant only
-catenin (HA18) cells, APC depletion did not cause a change
in HIF-1 mRNA, depletion of APC in wild-type only -cate-
nin (HA85) cells resulted in increased HIF-1 mRNA (Figure
5A). In addition, we investigated whether increased HIF-1
mRNA translated to increased HIF-1 activity (Figure 5B). In
cells containing wild-type -catenin, depletion of APC resulted
in signiﬁcant increases in HIF-1 target genes such as Glut3,
CA9, ADM, PHD2, and BNIP3 (Figure 5B and Supplemental
Figure 4). However, in the presence of mutant -catenin, de-
pletion of APC did not cause any signiﬁcant changes in HIF-1
target genes (Figure 5B and Supplemental Figure 4). Addi-
tional analysis revealed that APC depletion in -catenin wild-
type cells resulted in more stabilized HIF-1 after MG132 treat-
ment (Figure 5C). Together, these results indicate that APC
modulation of HIF-1 mRNA requires intact regulation of
-catenin by APC.
APC/-Catenin Modulation of HIF-1 Depends on NF-B
We showed previously that the HIF-1 gene is under the
tight control of NF-B (van Uden et al., 2008; Kenneth et al.,
2009). NF-B is usually retained in the cytoplasm by the
action of a family of proteins called IBs. On activating
stimuli such as tumor necrosis factor (TNF)-,I B is de-
graded so NF-B can translocate into the nucleus and active
its targets (Perkins and Gilmore, 2006). The NF-B response
in the isogenic cell lines we used to investigate the role of
-catenin in modulating of HIF-1 was described recently
(Du et al., 2009). The Geller group demonstrated that Wnt/
-catenin regulates cytokine-induced NF-B activation (Du
et al., 2009). We analyzed NF-B activation in response to
TNF- in these cells by using a biochemical fractionation
assay and immunoﬂuorescence, to measure RelA transloca-
tion from the cytoplasm into the nucleus (Supplemental
Figure 5, A and B). We conﬁrmed that in wild-type -catenin
cells, TNF- induced p65/RelA nuclear translocation, whereas
in the parental HCT-116 cells and mutant -catenin only cells,
RelA nuclear translocation was attenuated (Supplemental Fig-
ure 5, A and B). In addition, the level of phosphorylated RelA
at Ser 536, a marker of NF-B activity, was also higher in
wild-type -catenin cells. Interestingly, phosphorylation of the
NF-B inhibitory protein IB- also was diminished in -cate-
nin mutant cells (Supplemental Figure 5C).
We next investigated whether in cell lines expressing
wild-type -catenin, NF-B is involved in the APC-mediated
modulation of HIF-1. We depleted RelA in combination
with APC by using siRNA. In HA85 cells, siRNA targeted
against RelA and APC efﬁciently reduced RelA and APC
protein by 50% (Figure 6A). Importantly, codepletion of
APC and RelA completely prevented the increase in HIF-1
mRNA achieved by APC depletion alone. Similar results
were also obtained in U2OS cells (Supplemental Figure 6).
Figure 5. Increased HIF-1 after APC deple-
tion requires wild-type -catenin. (A) HCT-
116 (parental, mutant, and wild-type -cate-
nin), HA85 (wild-type -catenin), and
HA18 (mutant -catenin) were transfected
with control or APC siRNA oligonucleotides
for 48 h before RNA extraction and exposed
or not to 1% O2 for 24 h. RT-qPCR was per-
formed for APC and HIF-1, with actin used
as a normalizing gene. The graph depicts
mean plus SD of a minimum of three inde-
pendent experiments performed in duplicate.
(B) HA85 (wild-type -catenin) and HA18
(mutant -catenin) were transfected with con-
trol or APC siRNA oligonucleotides for 48 h
before RNA extraction and exposed or not to
1% O2 for 24 h. RT-qPCR was performed for
the indicated HIF-1 target genes. The graph
depicts mean plus SD of a minimum of three
independent experiments performed in du-
plicate. Asterisk (*) indicates the level of sig-
niﬁcance. *p  0.05, **p  0.01, and ***p 
0.005. (C) HA85 (wild-type -catenin) and
HA18 (mutant -catenin) were transfected
with control, APC, or HIF-1 siRNA oligonu-
cleotides and treated where indicated with 50
M MG132 for 3 h before harvest. Whole cell
lysates were analyzed by immunoblot using
the indicated antibodies. ImageJ software was
used to quantify band intensity.
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and the subsequent increase in NF-B that result from APC
depletion up-regulate the HIF-1 gene.
APC Depletion Enhances HIF-1–mediated Cellular
Functions
We conﬁrmed the effect of deregulated -catenin on HIF-1
protein by using the isogenic HCT-116 cell lines. Consistent
with our mRNA data, we found cells with wild-type -cate-
nin have higher levels of HIF-1 compared with those with
mutant -catenin cells (Figure 6B). This was mirrored by
HIF-1 activity as indicated by elevated levels of Glut3 in
wild-type cells (Figure 6B).
Hypoxia induces several cellular changes, including auto-
phagy (Kenneth and Rocha, 2008). Autophagy is character-
ized by the formation of autophagosomes, which recycle
damaged organelles such as mitochondria, and it can con-
tribute to both cell survival and death (Levine and Kroemer,
2008; Yu et al., 2008). During autophagy, light chain 3 (LC3)
proteins are cleaved from LC3I and LC3II forms, and the
cleaved form associates with autophagosomes. The presence of
LC3II on autophagosomes as well as its conversion to its
cleaved form are indicators of autophagy (Morselli et al., 2009).
Because our results suggested that APC depletion en-
hances HIF-1 levels, we next investigated whether this
correlated with changes in levels of the autophagy marker
LC3II. When APC was depleted in wild-type -catenin cells
that were exposed to hypoxic conditions, LC3II levels were
higher than in control cells (Figure 6C). However, in -cate-
nin mutant cells, depletion of APC failed to increase this
autophagy marker (Figure 6C). Nevertheless, mutant -cate-
nin cells when depleted of APC, still up-regulate Wnt target
genes such as cyclin D1 (Figure 6C). To determine the con-
tribution of HIF-1 to hypoxia-induced autophagy, we de-
pleted cells of HIF-1 before hypoxia exposure. In the ab-
sence of HIF-1, hypoxia-induced cleavage of LC3 was
greatly reduced (Figure 6D). This is in accordance with
previous studies where HIF-1 has been shown to play a
prominent role in hypoxia-mediated autophagy (Zhang et
al., 2008; Wilkinson and Ryan, 2009; Liu et al., 2010; Menrad
et al., 2010). The effects of APC and HIF-1 in the two
different cell lines also were conﬁrmed using LC3 immuno-
ﬂuorescence (Figure S7). These results suggest that APC
depletion enhances HIF-1–mediated autophagy in cells
with an intact APC–-catenin regulatory pathway. In addi-
tion, we veriﬁed that APC and HIF-1 depletion resulted in
increased survival, proliferation, or both in these cells (Fig-
ure 6E). We found that APC depletion resulted in increased
colony numbers only in cells with wild-type -catenin. In
contrast, HIF-1 depletion resulted in reduced colony for-
mation in both cell types, even though the effect was more
prominent in cells with wild-type -catenin (Figure 6E).
These results demonstrate that the level of APC and HIF-1
directly affects the survival and proliferation of cells (Figure 7).
Figure 6. Increased HIF-1 after APC deple-
tion requires NF-B. (A) HA85 cells were
transfected with the indicated siRNA oligo-
nucleotides for 48 h before RNA extraction.
Where indicated, cells were exposed to 1% O2
for 24 h. RT-qPCR was performed for the
levels of HIF-1, RelA, and APC, with actin
used as normalizing gene. Graph depicts the
mean plus SD of a minimum of three inde-
pendent experiments performed in duplicate.
(B) HA85 and HA18 cells were treated with
1% O2 for 24 h before lysis. Whole cell lysates
were analyzed by immunoblot for the levels
of the indicated proteins. (C) HA85 and
HA18 cells transfected with control and
APC siRNA oligonucleotides for 48 h. Cells
were exposed to 1% O2 for 24 h before har-
vest. Whole cell lysates were analyzed by
Western blot using the indicated antibodies.
Arrows indicate LC3I and LC3II. (D) HA85
and HA18 cells transfected with control and
HIF-1 siRNA oligonucleotides for 48 h. Cells
were exposed to 1% O2 for 24 h before har-
vest. Whole cell lysates were analyzed by
Western blot using the indicated antibodies.
Arrows indicate LC3I and LC3II. (E) Survival
effects of APC and HIF-1 depletion in
HA85 and HA18 cells. Cells were trans-
fected with siRNA oligonucleotides for APC
and HIF-1 as indicated. 24 h posttransfec-
tion, cells were counted and the indicated
number of cells were plated and allowed to
grow for additional 7 d before ﬁxation and
crystal violet staining. Plates were scanned
and ImageJ software was used to count colo-
nies.
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In this report, we uncovered an antagonistic relationship
between the tumor suppressor APC and the hypoxia acti-
vated transcription factor HIF-1, two important genes in-
volved in development as well as in cancer progression and
suppression. Although HIF-1 represses the APC gene di-
rectly, APC-mediated repression of HIF-1 relies on con-
trolled changes in the levels of -catenin and NF-B.
We found that HIF-1 represses the APC gene directly via
a functional HRE in the APC promoter (Figures 1 and 2 and
Supplemental Figures 1 and 2). In this case, HIF-1 binding
results in repression of APC mRNA and protein. This reveals
an important mechanism for how hypoxia can promote cell
survival. HIF-1–repressive activities are not well understood.
However, its ability to repress DNA repair genes such as
MSH2 and MSH6 is established (Yoo et al., 2009). Our data thus
uncovered APC as a novel HIF-1–repressed gene. We ob-
served that hypoxia induced the repression of wild-type and
mutant APC. The consequence of losing mutated APC in hy-
poxic tumor cells is not clear. It is possible that mutant APC has
functions that are different from wild-type APC. However,
such pathways have not been fully elucidated, but they may
involve other aspects of APC biology such as cytoskeletal reg-
ulation. In the future, it will be necessary to investigate how
non-Wnt–related processes mediated by APC are affected by
inhibition of mutant APC after hypoxia.
A crucial function of APC in cells is to limit the amount of
-catenin available for transcriptional activation and this is
induced by Wnt signaling. However, recent studies have
shown that after inactivation of APC, nuclear accumulation
of -catenin occurs later and at more advanced stages of
disease (Phelps et al., 2009). Furthermore, -catenin is not
uniformly nuclear in cells lacking APC and also can be
affected by other factors, including the extracellular matrix
and p53 (Brabletz et al., 2001; Damalas et al., 2001; Liu et al.,
2001). This suggests that cytoplasmic -catenin also may
play a role in other signaling pathways that can contribute to
cancer progression. Consistent with this idea, recent studies
showed that -catenin can alter NF-B function (Deng et al.,
2002, 2004; Du et al., 2009): whereas high levels of -catenin
(found in mutant APC or mutant -catenin–expressing cells)
inhibit NF-B activity, cells with low levels of -catenin have
normal NF-B activity (Du et al., 2009). We were able to
reproduce these results using HCT-116 cell lines that express
either wild-type or mutated (stabilized) -catenin (Supple-
mental Figure 5). Our data indicate that depletion of APC in
cells with wild-type -catenin leads to NF-B–mediated ac-
tivation of the HIF-1 gene. Although paradoxical (because
the elevated levels of -catenin that result from inactivation
of APC are expected to inhibit NF-B), this observation
might explain why inhibition of APC alone does not imme-
diately give rise to malignant tumors. In this scenario, the
elevated levels of HIF-1 could exert a protective effect
against tumorigenesis as observed in mouse models of
chemical induced carcinogenesis (Taylor and Colgan, 2007).
Furthermore, HIF-1 can control -catenin function (Kaidi et
al., 2007) and inhibit a variety of TCF4 target genes, includ-
ing c-myc and cyclin D1 (Lim et al., 2008). This means that
even after inhibition of APC, the resulting upregulation of
HIF-1 could delay Wnt signaling effects. However, the
situation can be reversed after prolonged lack of APC or in
the presence of constitutively high levels of -catenin. In
fact, in cells acclimatized to APC inhibition or with high
levels of -catenin, HIF-1 promotes Xenograft growth
(Dang et al., 2006). In this context, it is noteworthy that
although cells that express only mutant -catenin do not
up-regulate HIF-1 to the same extent as wild-type -cate-
nin–expressing cells when depleted of APC (Figure 6B),
they still up-regulate Wnt target genes such as cyclin D1
(Figure 6C) and they respond with a measurable, albeit
smaller, increase in -catenin transcriptional activity. This
may be due to a loss of APC from the cytoplasm where it
could normally act to sequester -catenin. Signiﬁcantly, we
show that in the context of a tissue, depletion of APC results
in increased HIF-1 activity (Figure 4A), thus establishing a
setting for our ﬁndings at an organism level.
The dual role of NF-B as either a tumor suppressor or an
oncogene has been extensively described previously (Perkins
and Gilmore, 2006). We found that depleting APC leads to
NF-B–mediated activation of HIF-1, whereas other studies
showed that APC overexpression can activate NF-B (Deng et
al., 2004). A more detailed analysis of the relative activity of
these different molecules at different stages of tumor progres-
sion is needed to determine how the balance of APC, -catenin,
and NF-B contributes to tumorigenesis. Importantly, our re-
sults suggest that prolonged hypoxia can induce oncogenic
changes in tumors that retain wild-type APC and -catenin.
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